nivolumab,ipilimumab,cabozantinib
bms,exelixis
['cosmic-313']
 such patient-centered modeling can be done for every rct, including cosmic-313, if individual-level data are provided to the public like calgb 40503 did. and that s the tip of the iceberg. coherent integration with knowledge across domains is now possible 
Physician-Scientist, Oncologist, PI #MsaouelLab @MDAndersonNews | Tweets=my views | #kidneycancer #RenalMedullaryCarcinoma #endRMC #rarecancers